Health Insurance Stock Could Rebound Off Historically Bullish Signal

Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn't enough to erase its worst day since March 2020 in the previous session, after the Centers for Medicare & Medicaid Services proposed to raise Medicare Advantage payment rates by only 0.09% in 2027.

Schaeffers Research • Jan 29, 2026

Elevance forecasts 2026 profit below estimates on elevated medical costs

Elevance Health forecast 2026 profit below Wall Street expectations on Wednesday, as the health insurer expects higher medical costs to persist into the year.

Reuters • Jan 28, 2026

Elevance Health Reports $547 Million Profit Despite Rising Costs

Elevance Health Wednesday reported fourth quarter net income of $547 million as healthcare cost issues continued to drag earnings of the health insurance giant.

Forbes • Jan 28, 2026

Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As we enter 2026, our focus is on advancing affordability and making healthcare easier to access and navigate for the members we serve. Through pricing discipline and targeted investments, we are strengthening the earnings power of our diversified.

Business Wire • Jan 28, 2026

Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain.

Elevance Health stock was set to fall for second consecutive day Wednesday.

Barrons • Jan 28, 2026

Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain

Elevance Health, Inc. faces persistent margin and volume pressures, with Q4 operating revenue down 55% YoY and weak 2026 guidance. ELV's benefit expense ratio remains elevated at 90%, with medical inflation and higher utilization driving cost pressures and reduced profitability. Guidance for 2026 anticipates revenue and EPS declines, with adjusted EPS expected to drop 16% and investment income down 15%.

Seeking Alpha • Jan 28, 2026

Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript

Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript

Seeking Alpha • Jan 28, 2026

US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026

Elevance Health Inc. (NYSE: ELV) shares fell after the health insurer reported mixed fourth-quarter 2025 earnings and bleak fiscal 2026 guidance. The stock has recovered most of its loss from the premarket session

Benzinga • Jan 28, 2026

Elevance Health (ELV) Beats Q4 Earnings Estimates

Elevance Health (ELV) came out with quarterly earnings of $3.33 per share, beating the Zacks Consensus Estimate of $3.1 per share. This compares to earnings of $3.84 per share a year ago.

Zacks Investment Research • Jan 28, 2026

Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Jan 28, 2026